P4395Characteristics of patients with heart failure prescribed sacubitril/valsartan in the primary care setting in Germany
Sven Klebs(Novartis (Germany)), Sara Bruce Wirta(Novartis (Switzerland)), Stefanie S Grunow, Raymond G. Schlienger(Novartis (Switzerland)), Markus Dworak(Novartis (Germany)), J. Engelhard(IQVIA (United Kingdom)), Matthias Schindler(University of Bern), F Calado(Novartis (Switzerland)), Catia C Proenca, Bogdan Balas(Roche (Switzerland))
Cited by 0
Related Papers
Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study
|The Lancet Child & Adolescent Health|2017|171
Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications
|European Journal of Clinical Pharmacology|2014|162
Real-World Treatment Patterns of Sacubitril/Valsartan: A Longitudinal Cohort Study in Germany
|European Journal of Heart Failure|2019|66
Burden of heart failure on caregivers in China: results from a cross-sectional survey
|Drug Design Development and Therapy|2018|48